Openbookopenbook
Equity
TEM
+0.0 · +0.00%
USD · NASDAQ

Tempus AI, Inc. Class A Common Stock(TEM) Stock Analysis | Healthcare

USD --+0.00%
Reward56Moderate
Risk78High
75%Data
Thin -18% profit margin · Revenue growing 22% YoY
Profitless Growth
Market Cap:11.56Bn
ⓘ
Reward Rating
56
Moderate
Reward Assessment
75% data coverage
Bottom 50% of stocksView factors
ⓘ
Risk Rating
78
High
Risk Assessment
7 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on TEM to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for TEM, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $63.36.

What is Tempus AI, Inc. Class A Common Stock?

operates as a healthcare technology company in the United States.

TEM · Verdict

Solid reward · high risk

TEM's standout is growth; volatility and cash flow weigh on the picture.

Based on 88% data coverage

TEM · Verdict

What’s working & what to watch

Strengths 1

  • Growth74/100

    Rev +58.3% CAGR · earnings -5.4%

Watchouts 4

  • Volatility5/100

    Weak vs peers

  • Cash flow16/100

    -19% free-cash-flow margin

  • Balance sheet30/100

    Current ratio 3.13

  • Profitability32/100

    -19% net margin · -67% ROE

Model-based scoring. For information only — not financial advice.

What is Tempus AI, Inc. Class A Common Stock?

operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 11.56B.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Elevated volatility implies higher downside and expectation risk.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (56)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Health Information Services names that are close enough in size to make side-by-side comparison useful.

BTSGLarge Cap / 11.6B market cap
BrightSpring Health Services, Inc. Common Stock
Compare
VEEVLarge Cap / 39.6B market cap
Veeva Systems Inc Class A
Compare
PMDIYMid Cap / 9.9B market cap
PMDIY
Compare
Company Information
SectorHealthcare
IndustryHealth Information Services
Market Cap11.56B
P/E RatioN/A
Dividend YieldN/A
Beta3.578
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
1166,250 shares
$7.7M
0
6-9months
17596,035 shares
$37.5M
0
9-12months
1166,250 shares
$12.3M
0
1 disclosure without share count
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.